Navigation Links
ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
Date:6/21/2010

om/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward-Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, and include without limitation statements related to the anticipated capacity of the industrial scale manufacturing process; increased future demand for Cinryze and our ability to meet projected demand growth for Cinryze; our belief that the industrial scale data meet the FDA's required equivalence criteria; the timing and outcomes of FDA review of the data; when product produced by the industrial scale manufacturing process may be commercially available; and our ability to ensure that patients will have access to Cinryze. Biologics such as Cinryze require processing steps that are more difficult than those required for most chemical pharmaceuticals, and as such we can not assure you that the industrial scale process will be considered by the FDA to be equivalent to our existing manufacturing process. The FDA may view the data regarding equivalence of the industrial scale manufacturing process as insufficient or inconclusive, request additional data, require additional studies, delay any decision past the time frames anticipated by us, or deny the approval of the industrial scale manufacturing process. If the manufacturing capacity expansion projects at Sanquin are delayed, or do not result in the capacity we anticipate, or if Sanquin cannot obtain necessary regulatory approvals for the contemplated facility expansions in the time frames we anticipate, we may not be able to satisfy patient demand. Our inability to obtain adequate product supplies to satisfy our patient demand may create opportunities for our competitors and we will suffe
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 , Elbit Imaging ... EMITF ) announced today following the Company,s announcement dated ... Medical") (TASE: EMTC-M), a subsidiary of the Company in ... basis, announced that on September 1, 2014 Gamida Cell ... the voting power ("Gamida Cell") and vast majority of ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Cepheid ... Flu/RSV XC, an on-demand molecular test for ... Flu B, and differentiation of RSV infection. The ... under the European Directive on In Vitro ... of tests available to eighteen. Xpert Flu/RSV XC runs ...
(Date:9/2/2014)... New York , September 2, 2014 ... " Biological Drugs Market - Global Industry Analysis, ... is expected to grow at a CAGR of 10.1% ... typically derived from living cells and are used in ... cancer, blood-related diseases, auto-immune diseases and other medical disorders. ...
Breaking Medicine Technology:Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6
... TECH ) announced that its Board of Directors has ... the quarter ended September 30, 2010.  The quarterly dividend will ... record on November 8, 2010.  Future cash dividends will be ... Techne Corporation has two operating subsidiaries:  Research and ...
... ALTO, Calif., Oct. 28 Jazz Pharmaceuticals, Inc. (Nasdaq: ... third quarter 2010 financial results on Thursday, November 4, 2010 ... will discuss its financial results and guidance for 2010, and ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , ... financing company LeaseQ, Inc. to help customers acquire capital ... 2012, LeaseQ’s breakthrough finance shopping platform has enabled businesses ... to run their business. , Said LeaseQ Vice ... ThermoTek sales team to provide customers faster access to ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group (AHDPG) ... its ICD-10 Medical Coding Bridge Program. The purpose of ... confidence to students who are seeking to launch an ... with the uncertainty brought on by the federal government’s ... 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple and ...
(Date:9/2/2014)... News) -- The quality of Americans, diets has improved ... the rich and poor is growing, a new study ... to date that the extensive efforts by many groups ... some payoff, but it also indicates that these efforts ... doctoral student in the department of nutrition at the ...
(Date:9/2/2014)... By Amy Norton ... -- For people who want to lose weight and boost ... than trimming dietary fat, a new study suggests. In ... those assigned to follow a low-carbohydrate diet lost more weight ... They also had bigger improvements in their cholesterol and ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 The ... Rehabilitation Hospital returns on September 19 at The ACE ... Pennsylvania. Over the past 25 years, the Classic, organized ... than $12 million for programs and services designed to ... Magee Rehabilitation Hospital. , “The Segal Classic is ...
Breaking Medicine News(10 mins):Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Quality of U.S. Diet Improves, Slightly 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2
... ... can now take advantage of its platform for rapid delivery of custom business applications. ,Formotus ... the first time today at the Mobile World Congress. Formotus demonstrated its mobile software in ... Barcelona, ...
... ... Georgia has become the company’s Vice President of Product Services. Among his responsibilities, Randy ... & Notification Network, White Pine’s flagship personal health record solution. , ... (PRWEB) February 14, 2010 -- ...
... ... Society of Aesthetic Plastic Surgery indicates a 162 percent increase in aesthetic ... continuing to rise, many men and women consider a tummy tuck (abdominoplasty) ... appropriate for their needs. At his practice offering plastic surgery in ...
... , ... Training and Consulting Inc., is bringing a unique approach to the Continuous Process Improvement ... one business strategy. , ... Denver, CO (PRWEB) February 15, 2010 -- Mountain Home Training and Consulting Inc., ...
... in the Feb. 15 issue of the Journal of ... and poor sleep quality significantly increase the risk of motor ... were twice as likely to have had a crash if ... or reported having bad sleep (OR = 1.9). Eighty ...
... might not be the best way to learn what to ... popular medical dramas and found that doctors and nurses on ... according to a study released today that will be presented ... Toronto April 10 to April 17, 2010. "Television dramas ...
Cached Medicine News:Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 2Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 3Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 4Health News:Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 2Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 4Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2
... only powered 6-inch dermatome on the market. ... adult hands or a small child's face ... to run more efficiently, thus the motor ... temperature is much cooler. The Electro-Dermatome is ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Sinskey), blunt tip angled 45, 15.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles han...
Medicine Products: